Evidence map›Paper›PMID 31695365›Full record

ArticleInternational journal of nanomedicine2019

Green synthesis of AgNPs@PPE and its

Reza Habibipour, Leila Moradi-Haghgou, Abbas Farmany

Abstract read
In one paragraph

Article in International journal of nanomedicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Eco-Friendly Synthesis of Silver Nanoparticles UsingInternational journal of molecular sciences · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Comparative Study ofNanomaterials (Basel, Switzerland) · 2024
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Green synthesis of silver nanoparticles fromFrontiers in microbiology · 2022
    Article
  14. Review
  15. Antibacterial and antibiofilm potential of silver nanoparticles against antibiotic-sensitive and multidrug-resistant Pseudomonas aeruginosa strains.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2021
    Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Reza HabibipourDepartment of Microbiology, Hamedan Branch, Islamic Azad University, Hamedan, Iran.
Leila Moradi-HaghgouDepartment of Microbiology, Hamedan Branch, Islamic Azad University, Hamedan, Iran.
Abbas FarmanyDental Research Center, School of Dentistry, Hamadan University of Medical Sciences, Hamadan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBacteria are able to form biofilm on the biotic and abiotic surfaces which helps to protect themselves from deleterious conditions, predation, desiccation, and exposure to antibacterial substances. About 80% of bacterial infections are caused by those bacteria living in the biofilm.

methodsAn aqueous extract of black pomegranate peel was used for the synthesis of silver nanoparticles (AgNPs@PPE). The characteristics, anti-biofilm formation and cell toxicity of AgNPs@PPE were examined in vitro.

resultsAbsorbance at λ

conclusionThese data indicate that co-treatment of PPE and AgNPs@PPE significantly decreased the biofilm formation rate. Furthermore, no significant toxicity of AgNPs@PPE was shown against L929 cell line at 400 µg/ml concentration.

Indexed as

AnimalsBiofilmsCell LineCell SurvivalGreen Chemistry TechnologyKineticsMetal NanoparticlesMiceMicrobial Sensitivity TestsPlant ExtractsPomegranatePseudomonas aeruginosaSilverX-Ray DiffractionPlant ExtractsSilverAgNPsantibacterial activitygreen synthesispomegranate peel extract

Identifiers

PMID31695365
PMCPMC6718057

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.